| Diabetic Macular Edema |
2015-000959-24: Investigation of Eylea for patients with diabetic macular edema in an outpatient Setting. |
|
|
| Ongoing | 4 | 50 | Europe | Eylea, Injection, Eylea | Abteilung für Augenheilkunde, AKH Linz, Bayer | Diabetic Retinopathy and diabetic macular edema are leading causes for visual loss and blindness in young adults around the world., Diabetic Macular Edema, Diseases [C] - Eye Diseases [C11] | | | | |
2014-005700-24: Cytokine Levels within patients with diabetic macular edema. |
|
|
| Ongoing | 4 | 20 | Europe | Lucentis, Ozurdex, EMEA/H/C/000715, EU/1/10/638/001, Injection, Intravitreal implant in applicator, Lucentis, Ozurdex | Abteilung für Augenheilkunde, AKH Linz, Bayer | Diabetic Retinopathy and diabetic macular edema are leading causes for visual loss and blindness in young adults around the world., Diabetic Macular Edema, Diseases [C] - Eye Diseases [C11] | | | | |
2016-004488-38: Investigation of the influence of the corticosteroid agent Iluvien on inflammation and growth factors in the eye of patients suffering from diabetic-related retina damage with swelling of the centre of the retina Untersuchung des Einflusses des Kortikosteroid-Medikamentes Iluvien auf die Entzündungs- und Wachstumsfaktoren im Auge von Patienten, die untereiner Diabetes-bedingten Netzhautschädigung mit Schwellung der Netzhautmitte leiden |
|
|
| Ongoing | 4 | 12 | Europe | Intravitreal implant in applicator, ILUVIEN 190 Mikrogramm intravitreales Implantat im Applikator | J. W. Goethe University, represented by dean of the medical faculty, Alimera Sciences Ophthalmologie GmbH | Diabetic related Macula edema Diabetisches Makulaödem, Diabetic-related retina damage with swelling of retina centre Diabetes-bedingte Netzhautschädigung mit Schwellung der Netzhautmitte, Diseases [C] - Eye Diseases [C11] | | | | |
2020-003515-10: To Study Aqueous Humor Composition and Retinal Imaging Features in Response to Anti-VEGF in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema STUDIE BIOMARKERŮ INHIBITORŮ VEGF ZKOUMAJÍCÍ VZTAH MEZI SLOŽENÍM KOMOROVÉ VODY A MULTIMODÁLNÍMI SNÍMKY SÍTNICE PŘI VLHKÉ FORMĚ VĚKEM PODMÍNĚNÉ MAKULÁRNÍ DEGENERACE A DIABETICKÉM MAKULÁRNÍM EDÉMU |
|
|
| Ongoing | 4 | 200 | RoW | Aflibercept, Solution for injection in pre-filled syringe, Eylea® | F. Hoffmann-La Roche Ltd, F. Hoffmann-La Roche Ltd | Treatment Naïve Neovascular Age-Related Macular Degeneration (nAMD) and Treatment Naïve diabetic macular edema (DME), nAMD is an eye disease particularly affects the center of sharp vision (e.g affects reading or driving). DME is a complication of diabetes and causes problem in vision (e.g blurred or wavy vision)., Diseases [C] - Eye Diseases [C11] | | | | |
NCT04464694: Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema |
|
|
| Not yet recruiting | 4 | 142 | RoW | Ranibizumab, Lucentis, Sham injection, Pars plana vitrectomy, Vitrectomy | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Novartis | Proliferative Diabetic Retinopathy, Diabetic Macular Edema | 12/21 | 06/22 | | |
STAMP, NCT03832179: Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification |
|
|
| Recruiting | 4 | 32 | US | Bevacizumab, Avastin, Ranibizumab, Lucentis, Aflibercept, Eylea, Ozurdex, Dexamethasone implant | Bay Area Retina Associates, Allergan | Diabetic Macular Edema, Cataract | 07/22 | 10/22 | | |
2018-004785-33: Study to Evaluate the Efficacy and Safety of OZURDEX® in Treatment Naïve Patients with Diabetic Macular Edema Estudio para evaluar la eficacia y seguridad de OZURDEX® ) en pacientes sin tratamiento previo con edema macular diabetic |
|
|
| Not yet recruiting | 4 | 150 | Europe | OZURDEX®, Intravitreal implant in applicator, OZURDEX® | Allergan Pharmaceuticals International Limited, Allergan Pharmaceuticals International Limited | Diabetic Macular Edema Edema Macular Diabético, Diabetic Macular Edema Edema Macular Diabético, Diseases [C] - Eye Diseases [C11] | | | | |
DETeR, NCT04563299: Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections |
|
|
| Terminated | 4 | 10 | US | Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate | Retina Vitreous Associates of Florida, Ocular Therapeutix, Inc. | Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion | 02/23 | 02/23 | | |
PRECISION, NCT04411693: Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema |
|
|
| Completed | 4 | 23 | US | Dexamethasone implant, Ozurdex, Aflibercept, Eylea | The Cleveland Clinic, Allergan | Diabetic Macular Edema | 01/24 | 01/24 | | |
INSITE-DME, NCT05610319: Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial |
|
|
| Recruiting | 4 | 446 | Europe, Canada, US, RoW | Faricimab | McMaster University, Hoffmann-La Roche | Diabetic Macular Edema | 08/26 | 08/26 | | |
VISION-AF, NCT05511038: A Study to Learn How Safe the Study Drug Intravitreal (Given by an Injection Into the Eye) Aflibercept is in Participants in India With Diabetic Macular Edema |
|
|
| Completed | 4 | 100 | RoW | Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321) | Bayer | Diabetic Macular Edema | 04/24 | 04/24 | | |
NCT04469595: A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME) |
|
|
| Active, not recruiting | 4 | 300 | US | Iluvien 0.19 MG Drug Implant, ILUVIEN, Aflibercept, Eylea | Alimera Sciences | Diabetic Macular Edema | 12/24 | 12/24 | | |
NCT05224102: A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema |
|
|
| Recruiting | 4 | 218 | US, RoW | Faricimab, VABYSMO™, RO6867461, RG7716 | Genentech, Inc. | Diabetic Macular Edema | 11/26 | 11/26 | | |
